▶ 調査レポート

反芻動物ワクチンの世界市場2023:弱毒生ワクチン、不活化ワクチン、その他

• 英文タイトル:Global Ruminant Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。反芻動物ワクチンの世界市場2023:弱毒生ワクチン、不活化ワクチン、その他 / Global Ruminant Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC2306GIR0623資料のイメージです。• レポートコード:MRC2306GIR0623
• 出版社/出版日:GlobalInfoResearch / 2023年6月
• レポート形態:英語、PDF、117ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&医療
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の反芻動物ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の反芻動物ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 反芻動物ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

反芻動物ワクチン市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・弱毒生ワクチン、不活化ワクチン、その他

用途別セグメント
・牛、羊、その他

主要な市場プレーヤー
・Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories、FATRO、Vaksindo

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、反芻動物ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な反芻動物ワクチンメーカーの企業概要、2019年~2022年までの反芻動物ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な反芻動物ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別反芻動物ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの反芻動物ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での反芻動物ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および反芻動物ワクチンの産業チェーンを掲載しています。
・第14、15章では、反芻動物ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 反芻動物ワクチンの概要
- 種類別分析(2018年vs2022年vs2029年):弱毒生ワクチン、不活化ワクチン、その他
- 用途別分析(2018年vs2022年vs2029年):牛、羊、その他
- 世界の反芻動物ワクチン市場規模・予測
- 世界の反芻動物ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories、FATRO、Vaksindo
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:弱毒生ワクチン、不活化ワクチン、その他
・用途別分析2018年-2029年:牛、羊、その他
・反芻動物ワクチンの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・反芻動物ワクチンのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・反芻動物ワクチンのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・反芻動物ワクチンの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・反芻動物ワクチンの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Ruminant Vaccines market size was valued at USD 2511.7 million in 2022 and is forecast to a readjusted size of USD 3736.3 million by 2029 with a CAGR of 5.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
This report is a detailed and comprehensive analysis for global Ruminant Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ruminant Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ruminant Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ruminant Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ruminant Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ruminant Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ruminant Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva and CAHIC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ruminant Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Market segment by Application
Cattle
Sheep
Other
Major players covered
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ruminant Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ruminant Vaccines, with price, sales, revenue and global market share of Ruminant Vaccines from 2018 to 2023.
Chapter 3, the Ruminant Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ruminant Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ruminant Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ruminant Vaccines.
Chapter 14 and 15, to describe Ruminant Vaccines sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Ruminant Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ruminant Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live Attenuated Vaccines
1.3.3 Inactivated Vaccines
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Ruminant Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cattle
1.4.3 Sheep
1.4.4 Other
1.5 Global Ruminant Vaccines Market Size & Forecast
1.5.1 Global Ruminant Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Ruminant Vaccines Sales Quantity (2018-2029)
1.5.3 Global Ruminant Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Ruminant Vaccines Product and Services
2.1.4 Merck Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Ruminant Vaccines Product and Services
2.2.4 Zoetis Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Ruminant Vaccines Product and Services
2.3.4 Boehringer Ingelheim Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Ruminant Vaccines Product and Services
2.4.4 Ceva Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Recent Developments/Updates
2.5 CAHIC
2.5.1 CAHIC Details
2.5.2 CAHIC Major Business
2.5.3 CAHIC Ruminant Vaccines Product and Services
2.5.4 CAHIC Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CAHIC Recent Developments/Updates
2.6 HVRI
2.6.1 HVRI Details
2.6.2 HVRI Major Business
2.6.3 HVRI Ruminant Vaccines Product and Services
2.6.4 HVRI Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 HVRI Recent Developments/Updates
2.7 Ringpu Biology
2.7.1 Ringpu Biology Details
2.7.2 Ringpu Biology Major Business
2.7.3 Ringpu Biology Ruminant Vaccines Product and Services
2.7.4 Ringpu Biology Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ringpu Biology Recent Developments/Updates
2.8 Yebio
2.8.1 Yebio Details
2.8.2 Yebio Major Business
2.8.3 Yebio Ruminant Vaccines Product and Services
2.8.4 Yebio Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Yebio Recent Developments/Updates
2.9 DHN
2.9.1 DHN Details
2.9.2 DHN Major Business
2.9.3 DHN Ruminant Vaccines Product and Services
2.9.4 DHN Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DHN Recent Developments/Updates
2.10 WINSUN
2.10.1 WINSUN Details
2.10.2 WINSUN Major Business
2.10.3 WINSUN Ruminant Vaccines Product and Services
2.10.4 WINSUN Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 WINSUN Recent Developments/Updates
2.11 Elanco
2.11.1 Elanco Details
2.11.2 Elanco Major Business
2.11.3 Elanco Ruminant Vaccines Product and Services
2.11.4 Elanco Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Elanco Recent Developments/Updates
2.12 Virbac
2.12.1 Virbac Details
2.12.2 Virbac Major Business
2.12.3 Virbac Ruminant Vaccines Product and Services
2.12.4 Virbac Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Virbac Recent Developments/Updates
2.13 Jinyu Bio-Technology
2.13.1 Jinyu Bio-Technology Details
2.13.2 Jinyu Bio-Technology Major Business
2.13.3 Jinyu Bio-Technology Ruminant Vaccines Product and Services
2.13.4 Jinyu Bio-Technology Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jinyu Bio-Technology Recent Developments/Updates
2.14 ChengDu Tecbond
2.14.1 ChengDu Tecbond Details
2.14.2 ChengDu Tecbond Major Business
2.14.3 ChengDu Tecbond Ruminant Vaccines Product and Services
2.14.4 ChengDu Tecbond Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ChengDu Tecbond Recent Developments/Updates
2.15 CAVAC
2.15.1 CAVAC Details
2.15.2 CAVAC Major Business
2.15.3 CAVAC Ruminant Vaccines Product and Services
2.15.4 CAVAC Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CAVAC Recent Developments/Updates
2.16 Kyoto Biken Laboratories
2.16.1 Kyoto Biken Laboratories Details
2.16.2 Kyoto Biken Laboratories Major Business
2.16.3 Kyoto Biken Laboratories Ruminant Vaccines Product and Services
2.16.4 Kyoto Biken Laboratories Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Kyoto Biken Laboratories Recent Developments/Updates
2.17 FATRO
2.17.1 FATRO Details
2.17.2 FATRO Major Business
2.17.3 FATRO Ruminant Vaccines Product and Services
2.17.4 FATRO Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 FATRO Recent Developments/Updates
2.18 Vaksindo
2.18.1 Vaksindo Details
2.18.2 Vaksindo Major Business
2.18.3 Vaksindo Ruminant Vaccines Product and Services
2.18.4 Vaksindo Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Vaksindo Recent Developments/Updates
3 Competitive Environment: Ruminant Vaccines by Manufacturer
3.1 Global Ruminant Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Ruminant Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Ruminant Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Ruminant Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Ruminant Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Ruminant Vaccines Manufacturer Market Share in 2022
3.5 Ruminant Vaccines Market: Overall Company Footprint Analysis
3.5.1 Ruminant Vaccines Market: Region Footprint
3.5.2 Ruminant Vaccines Market: Company Product Type Footprint
3.5.3 Ruminant Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ruminant Vaccines Market Size by Region
4.1.1 Global Ruminant Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Ruminant Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Ruminant Vaccines Average Price by Region (2018-2029)
4.2 North America Ruminant Vaccines Consumption Value (2018-2029)
4.3 Europe Ruminant Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Ruminant Vaccines Consumption Value (2018-2029)
4.5 South America Ruminant Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Ruminant Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Ruminant Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Ruminant Vaccines Consumption Value by Type (2018-2029)
5.3 Global Ruminant Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Ruminant Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Ruminant Vaccines Consumption Value by Application (2018-2029)
6.3 Global Ruminant Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Ruminant Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Ruminant Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Ruminant Vaccines Market Size by Country
7.3.1 North America Ruminant Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Ruminant Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Ruminant Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Ruminant Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Ruminant Vaccines Market Size by Country
8.3.1 Europe Ruminant Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Ruminant Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Ruminant Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Ruminant Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Ruminant Vaccines Market Size by Region
9.3.1 Asia-Pacific Ruminant Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Ruminant Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Ruminant Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Ruminant Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Ruminant Vaccines Market Size by Country
10.3.1 South America Ruminant Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Ruminant Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Ruminant Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Ruminant Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Ruminant Vaccines Market Size by Country
11.3.1 Middle East & Africa Ruminant Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Ruminant Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Ruminant Vaccines Market Drivers
12.2 Ruminant Vaccines Market Restraints
12.3 Ruminant Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Ruminant Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ruminant Vaccines
13.3 Ruminant Vaccines Production Process
13.4 Ruminant Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ruminant Vaccines Typical Distributors
14.3 Ruminant Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer